New hope for tough cancers: first human test of experimental drug begins
NCT ID NCT05873686
Summary
This is the first study in people to test a new drug called NXP900 for advanced solid tumors. The main goals are to find a safe dose and see how the body processes the drug. The study will also look for early signs that the drug can shrink tumors, especially in cancers with specific genetic changes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic
RECRUITINGPhoenix, Arizona, 85054, United States
Contact Phone: •••-•••-••••
-
Mayo Clinic
RECRUITINGJacksonville, Florida, 32224, United States
Contact Phone: •••-•••-••••
-
Mayo Clinic Rochester
RECRUITINGRochester, Minnesota, 55905, United States
-
NEXT Oncology Dallas
RECRUITINGIrving, Texas, 75039, United States
-
NEXT Oncology Houston
RECRUITINGHouston, Texas, 77054, United States
-
NEXT Oncology Virginia
RECRUITINGFairfax, Virginia, 22031, United States
-
Oregon Health and Science University
RECRUITINGPortland, Oregon, 97239, United States
Contact Phone: •••-•••-••••
-
Sarah Cannon Research Institute at HealthONE
RECRUITINGDenver, Colorado, 80218, United States
Contact Phone: •••-•••-••••
-
The Royal Marsden NHS Foundation and Trust
COMPLETEDLondon, SW3 6JJ, United Kingdom
-
The University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-••••
-
University of Chicago
RECRUITINGChicago, Illinois, 60637, United States
-
Western General Hospital - NHS Lothian
COMPLETEDEdinburgh, EH4 2XU, United Kingdom
Conditions
Explore the condition pages connected to this study.